Uzbekistan Medical Device Registration Certificate Validity: Five-Year Term and Renewal

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The validity period of the Uzbek national registration certificate is uniformly 5 years, with domestic and foreign manufacturers treated equally; moreover, indefinite registration certificates previously issued to domestic manufacturers are converted to a 5-year term across the board from the entry into force of Presidential Decree No. UP-137 of August 19, 2025. Uzbekistan therefore has no pathway of registration valid once and forever, and no arrangement of the Kazakh type in which medical device registration certificates carry no expiry date. The compliance focus consequently extends from obtaining the certificate to two long-term actions: renewal and change management. For portfolio holders this conversion changes the nature of the asset: certificates that previously required no scheduling now carry a first renewal deadline measured from the decree effective date. Companies should treat the 5-year term as a fixed compliance cycle with its own preparation workload, covering updated powers of attorney, refreshed foreign approval status, post-market evidence and accumulated change requests, all of which must be assembled inside a narrow statutory window before expiry.

2. Legal basis

RegulationNumberDateProvisions
Presidential Decree on Additional Measures for Regulating the Circulation of Medicines and Medical DevicesNo. UP-137August 19, 2025Registration certificates with a 5-year validity period issued to domestic and foreign manufacturers as the result of state registration; prior indefinite certificates converted to 5 years from the effective date of the decree
Cabinet of Ministers Resolution on Approving the Regulation on State Registration of Medicines and Medical Devices and the Issuance of Registration CertificatesNo. 738Adopted November 24, 2025, effective February 26, 20265-year validity of registration certificates; renewal procedure
Cabinet of Ministers Resolution on Approving the Regulation on State Registration of Medicines, Medical-Use Products and Medical Equipment (superseded by Resolution No. 738)No. 213March 23, 2018 (amended December 7, 2023)Article 6: validity period of registration certificates is 5 years; Article 7: the certificate is the evidence of authorization for use in medical practice granted by the Ministry of Health; renewal applications must be filed 3 months before expiry, and the renewal fee is half the standard amount
Presidential Decree on Additional Measures for Regulating the Circulation of Medicines and Medical DevicesNo. UP-137August 19, 2025From January 1, 2026, state registration of medicines and renewal of registration certificate validity requires a national GMP certificate

3. Expert insights

Insight one: the 5-year term is the most unifying element of this reform. Presidential Decree No. UP-137 both brought foreign manufacturers under the 5-year term and converted the prior indefinite certificates of domestic manufacturers to 5 years. Before the reform, domestic manufacturers held certificates without a term while foreign manufacturers held 5-year certificates, and the two sets of rules ran in parallel; after the reform, the term is uniformly 5 years. The impact on existing certificate holders is that certificates which previously required no scheduling now need their first renewal completed within 5 years after the conversion starting point, which makes certificate portfolio planning an immediate task rather than a future one.

Insight two: the conversion starting point is the effective date of the decree, not the certificate issue date. Prior indefinite certificates run their 5 years from the date the decree took effect. This starting point directly determines the window for the first renewal, and companies should calculate backwards from the effective date after August 19, 2025, not from the issue date of the original certificate. A portfolio keyed to old issue dates will systematically misstate renewal deadlines, in some cases by several years, and the error typically surfaces only when an import consignment is checked against certificate validity.

Insight three: renewal is not automatic, and it requires post-market evidence. The renewal rules established by Resolution No. 213 require the applicant to file 3 months before expiry, with the fee charged at half the standard amount; at renewal, the registration file, post-market evidence and quality system status must also be updated. In practice, collecting local clinical use feedback, updating foreign approval status and re-authenticating powers of attorney all consume time, so 3 months is only the statutory floor. A preparation runway of two to three quarters is the realistic planning assumption for a renewal that passes without deficiencies.

Insight four: the treatment after expiry differs from the Kazakh approach. Under the old rules of Resolution No. 213, after a registration certificate expires, products manufactured during its validity may still be sold and used. This run-down arrangement prevents expiry from immediately cutting off all circulation. New applications and import actions, however, must be completed within the validity period, otherwise the goods constitute unregistered devices. Importers should therefore freeze new consignments against the expiry date even where legacy stock may continue to be sold.

4. Practical recommendations

  1. Build a registration certificate ledger recording, certificate by certificate, the issue date, the expiry date and the statutory renewal window (3 months before expiry).
  2. For legacy indefinite certificates, run the 5 years from the decree effective date after August 19, 2025 and mark the first renewal point separately.
  3. Start renewal preparation early: update powers of attorney and their authentication, refresh foreign approval status, and collect post-market use feedback.
  4. Handle accumulated changes together with the renewal application, avoiding a separate change procedure after renewal.
  5. Set an early warning before expiry in the ledger, with import and shipment plans suspended automatically once the certificate lapses.

5. Verification checklist

  • □ A registration certificate ledger has been established with issue dates and expiry dates marked certificate by certificate
  • □ The statutory renewal window (3 months before expiry) has been entered in the ledger with an early warning
  • □ Legacy indefinite certificates run their 5 years from the decree effective date with the first renewal point marked
  • □ Power of attorney authentication, foreign approval status and post-market evidence required for renewal are on the preparation list
  • □ The national GMP certificate requirement for medicine renewals (from January 1, 2026) has been confirmed
  • □ Import and shipment of goods after certificate expiry are subject to an automatic suspension mechanism

Regulatory information verified as of October 29, 2026.

GRZAN provides registration support in Uzbekistan for manufacturers, importers and authorized representatives. For assistance with certificate renewal and portfolio management, contact info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail